-Lariox Pharma, Fidia Pharmaceutici's Regulatory Partner in Egypt, Enhances Marketing Team's Pharmacovigilance Expertise july 2021

Lariox Pharma, the trusted regulatory partner of Fidia Pharmaceutici in Egypt, has successfully imparted critical pharmacovigilance knowledge to the latter’s marketing team. Through a comprehensive training program, Lariox Pharma equipped the marketing professionals with a deep understanding of pharmacovigilance's pivotal role in safeguarding patient safety.

The training emphasized the scientific methodologies for reporting and collecting adverse event data, empowering the Fidia Pharmaceutici team to contribute proactively to patient safety initiatives. This collaboration underscores the shared commitment of both companies to upholding the highest standards of pharmaceutical care in the Egyptian market.